STAT Readers on Animal Testing: Views & Opinions
Experts clash over the role of animal models in biomedical research, stirring a heated debate about animal testing alternatives. This STAT First Opinion platform’s series unpacks the critical perspectives of scientists and advocates,exploring both sides of this complex issue.Discover a veterinarian’s account of a drug’s unexpected toxicity in an animal model, highlighting the potential risks of bypassing animal testing. Then, review arguments for non-animal methods and their role in medical breakthroughs. Uncover the ethical implications and advancements shaping the future of research; News Directory 3 follows the crucial developments in responsible science. Discover what’s next for the ongoing debate.
Animal testing alternatives spark debate
Updated Month DD,YYYY
The use of animal models in biomedical research remains a contentious topic,with experts on both sides of the issue weighing in on their value and the potential of alternatives. A recent series of essays published on STATS First Opinion platform has ignited a fresh round of debate, highlighting the complexities and nuances of this ongoing discussion.
Caitlin Vonderohe, a veterinarian and biomedical researcher specializing in pediatrics, argues that animal models are indispensable for ensuring the safety and scientific integrity of medical research. She recounts an instance where a drug candidate, seemingly safe in cell models and healthy adults, exhibited toxicity in an animal model of a preterm infant. Vonderohe contends that bypassing animal models could have had disastrous consequences in that case.
“Giving a person a candidate compound without an idea of how that compound will interact with the 80-plus organs and more than 200 cell types that make up a human being could be disastrous,” Vonderohe said.
Andrew Rowan of WellBeing International counters that history shows that biomedical innovation can flourish even with reduced reliance on animal models. He notes that Great Britain has seen a 70% decline in laboratory animal use as 1975, while still producing significant medical advancements.Rowan points to the discovery of insulin and the progress of the polio vaccine as examples where non-animal methods played a crucial role.
In a separate letter, Cynthia DeMott lamented the state of health care for vulnerable patients, while Patricia M. Speck, D.N.Sc., weighed in on at-home sexual assault kits. Richard Reibstein of Boston University commented on the origin of Sloan Kettering.
What’s next
As technology advances, the debate over animal testing alternatives is likely to intensify. Researchers will continue to explore new methods for studying disease and developing treatments, while also considering the ethical implications of their work.